Delivery Order SPE2DR25D3012-SPE2DR26F4E3Z
Award Date 1/5/26
Potential Completion Date 1/6/26
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,962.22 to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 mL syringes on September 5, 2025, with completion targeted for September 8, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a viscosupplement injection used to treat osteoarthritis pain, representing one of the specialized...
- The Defense Logistics Agency awarded a delivery order valued at $1,221.75 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 ml syringes (4 ml quantity) on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a viscosupplement injection used to treat osteoarthritis pain,...
- The Defense Logistics Agency awarded a delivery order valued at $19,860.40 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 ml syringes on a firm fixed-price basis. The order was competitively awarded without set-aside designation and is scheduled for completion by January 6, 2026, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a viscosupplement injection used in orthopedic and rheumatologic applications for managing joint...
- The Defense Logistics Agency awarded a delivery order valued at $4,233.00 to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 ml syringes on December 19, 2025, with completion targeted for December 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a viscosupplement injection used for osteoarthritis pain management, representing a specialized...
- The Defense Logistics Agency awarded a delivery order valued at $14,829.77 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes on September 24, 2025, with completion expected by September 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Monovisc is a viscosupplement injection used in orthopedic and rheumatological...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $14,155.08 on July 18, 2025, for the supply of Monovisc 88 mg/4 mL syringes through the Defense Logistics Agency Medical Supply Chain. The contract represents a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and involves no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Monovisc is a...
- The Defense Logistics Agency awarded a delivery order valued at $3,711.30 to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 mL syringes on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supplies to be performed at the awardee's facility in Conshohocken, Pennsylvania. Monovisc is a hyaluronic acid injection used for joint pain management, reflecting the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,551.43 on August 13, 2025, for the supply of Monovisc 88 mg/4 mL syringes. This firm fixed-price delivery order, which carries an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Monovisc is a viscosupplement injection used primarily for osteoarthritis joint pain...
- The Defense Logistics Agency awarded a delivery order valued at $9,089.29 to AmerisourceBergen Drug Corp for the supply of Monovisc 88 mg/4 mL syringes on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Monovisc is a hyaluronic acid-based joint injection used primarily for osteoarthritis pain...
- The Defense Logistics Agency awarded a $7,083.15 delivery order to AmerisourceBergen Drug Corp for Monovisc 88 mg/4 mL syringes on October 23, 2025, with an ultimate completion date of October 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Monovisc is a hyaluronic acid-based injection used for joint pain management and osteoarthritis treatment, representing a...